Promoting research integrity in funding: Co-creating guidelines for research funding organizations.

Research integrity funding process research funding organizations research integrity policies

Journal

Accountability in research
ISSN: 1545-5815
Titre abrégé: Account Res
Pays: United States
ID NLM: 9100813

Informations de publication

Date de publication:
28 Aug 2024
Historique:
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 28 8 2024
Statut: aheadofprint

Résumé

Research Funding Organizations (RFOs) play an important role in promoting research integrity (RI). Not only do they allocate resources to research institutions and researchers, but they also set and monitor research standards in their funded projects. In spite of their crucial role, there is a paucity of guidance on how RFOs can promote research integrity. As part of the EU-Funded SOPs4RI project, we aimed to address this gap by co-creating guidelines to help RFOs promote RI, engaging a diverse group of stakeholders. Based on a Delphi survey, reviews of evidence and stakeholder interviews, three guideline topics were identified: 1) the selection and evaluation of proposals; 2) monitoring of funded projects; and 3) prevention of unjustified interference. Four sets of co-creation workshops were conducted for each guideline topic, and the input revised and finalized. Understanding these debates could help RFOs from diverse cultural and organizational backgrounds who are developing their own RI guidelines. Therefore, in this paper, we summarize the key results and emphasize the final recommendations. Further, we provide the main points of discussion that occurred during the workshops and explain how they were addressed or resolved in the final guidelines and how they can help in future endeavors to improve funders' practices to foster RI.

Identifiants

pubmed: 39194959
doi: 10.1080/08989621.2024.2388232
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-20

Auteurs

Roshni Jegan (R)

Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Krishma Labib (K)

Department of Ethics, Law and Humanities, Amsterdam Public Health Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Kris Dierickx (K)

Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

Noémie Aubert Bonn (N)

Department of Ethics, Law and Humanities, Amsterdam Public Health Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Healthcare and Ethics, Hasselt University, Hasselt, Belgium.

Joeri Tijdink (J)

Department of Ethics, Law and Humanities, Amsterdam Public Health Institute, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Philosophy, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Ana Marušić (A)

Center for Evidence-based Medicine, Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.

Daniel Pizzolato (D)

Centre for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
European Network of Research Ethics Committees, Bonn, Germany.

Classifications MeSH